Lakeshore Biopharma Co, Stock Retained Earnings
| LSB Stock | 2.75 0.23 7.72% |
LakeShore Biopharma Co, fundamentals help investors to digest information that contributes to LakeShore Biopharma's financial success or failures. It also enables traders to predict the movement of LakeShore Stock. The fundamental analysis module provides a way to measure LakeShore Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LakeShore Biopharma stock.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | -2.3 B | -2.2 B |
LakeShore | Retained Earnings |
LakeShore Biopharma Co, Company Retained Earnings Analysis
LakeShore Biopharma's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current LakeShore Biopharma Retained Earnings | (2.31 B) |
Most of LakeShore Biopharma's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LakeShore Biopharma Co, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
LakeShore Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for LakeShore Biopharma is extremely important. It helps to project a fair market value of LakeShore Stock properly, considering its historical fundamentals such as Retained Earnings. Since LakeShore Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LakeShore Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LakeShore Biopharma's interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, LakeShore Biopharma Co, has a Retained Earnings of (2.31 Billion). This is 347.76% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 124.73% higher than that of the company.
LakeShore Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LakeShore Biopharma's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LakeShore Biopharma could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics of similar companies.LakeShore Biopharma is currently under evaluation in retained earnings category among its peers.
LakeShore Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.76) % | ||||
| Operating Margin | (0.69) % | ||||
| Current Valuation | 139.31 M | ||||
| Shares Outstanding | 190.81 M | ||||
| Shares Owned By Insiders | 81.34 % | ||||
| Shares Owned By Institutions | 2.68 % | ||||
| Number Of Shares Shorted | 47.52 K | ||||
| Price To Book | 1.39 X | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 573.42 M | ||||
| EBITDA | (368.66 M) | ||||
| Net Income | (433.46 M) | ||||
| Total Debt | 424.46 M | ||||
| Book Value Per Share | 3.08 X | ||||
| Cash Flow From Operations | (295.23 M) | ||||
| Short Ratio | 1.07 X | ||||
| Earnings Per Share | (0.57) X | ||||
| Target Price | 4.19 | ||||
| Number Of Employees | 758 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 114.29 M | ||||
| Total Asset | 1.51 B | ||||
| Retained Earnings | (2.31 B) | ||||
| Working Capital | 100.94 M | ||||
| Net Asset | 1.51 B |
About LakeShore Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LakeShore Biopharma Co,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LakeShore Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LakeShore Biopharma Co, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LakeShore Biopharma Co, is a strong investment it is important to analyze LakeShore Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LakeShore Biopharma's future performance. For an informed investment choice regarding LakeShore Stock, refer to the following important reports:Check out LakeShore Biopharma Piotroski F Score and LakeShore Biopharma Altman Z Score analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Revenue Per Share 5.363 | Quarterly Revenue Growth 0.277 | Return On Assets (0.14) | Return On Equity (0.66) |
The market value of LakeShore Biopharma Co, is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.